Advanced Malignancies Clinical Trials

A listing of Advanced Malignancies medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 856 clinical trials
None
A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies

The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics, pharmacodynamics, and early clinical activity of single-agent INCB081776 (Part 1) and INCB081776 in combination with INCMGA00012 (Part 2).

  • 16 views
  • 07 Oct, 2021
  • 7 locations
None
Safety and Pharmacokinetics of REGN2810 (Cemiplimab) (Anti-PD-1) in Japanese Patients With Advanced Malignancies

The primary objective of the study is to assess the safety, tolerability, and Pharmacokinetics (PK) of cemiplimab in Japanese patients with advanced malignancies. The secondary objectives

ipilimumab
  • 15 views
  • 19 Nov, 2021
  • 23 locations
None
Safety and Efficacy of IBI322 in Chinese Subjects With Advanced Malignant Tumors

This is a phase I study evaluating the safety, tolerability and preliminary efficacy of IBI322 in cancer subjects who failed standard treatment.

  • 0 views
  • 25 Jan, 2021
None
A Study of SHR-1501 Combined With SHR-1316 in Patients With Advanced Tumors

The purpose of this study is to evaluate the safety and tolerability of SHR-1501 in combination with SHR-1316 in patients with advanced malignancies and to provide a recommended dose (RP2D) for

  • 17 views
  • 24 Jan, 2021
  • 5 locations
None
A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

The study is investigating efficacy, safety and tolerability of DNA-damage Response Agents (or Combinations), in participants with advanced/metastatic solid malignancies whose tumours contain molecular alterations

  • 0 views
  • 12 Sep, 2021
  • 23 locations
None
BI-1808 as a Single Agent and With Pembrolizumab in Treatment of Advanced Malignancies

advanced malignancies, whose disease has progressed after standard therapy. For the purpose of this study, subjects with advanced malignancies includes subjects with advanced solid tumors (where

  • 4 views
  • 21 Aug, 2021
  • 8 locations
None
  • 0 views
  • 16 Feb, 2021
  • 1 location
None
Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors

An open-label, multicenter, phase Ia/Ib study to evaluate the safety, tolerance and preliminary efficacy of IBI319 in patients with advanced malignant tumors

  • 0 views
  • 15 May, 2021
  • 1 location
None
A Clinical Study Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumours

This is a phase I/II, open-label, dose escalation and dose extension study to evaluate the safety, tolerability, PK, and preliminary efficacy of LM-061 in subjects with advanced tumors.

  • 0 views
  • 07 Jun, 2021
  • 1 location
None
The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies.

Safety and tolerability of pemigatinib.in monotherapy or combination in patients that have participated in a previous parent study to treat advanced malignancies.

  • 0 views
  • 24 Nov, 2021
  • 4 locations